Effectiveness of Enhanced External Counterpulsation for Post-acute Stroke Patients
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: enhanced external counterpulsation, post acute care.
- Кому может быть актуально
- Состояния в реестре: Cerebrovascular Accident (CVA). Базовые параметры: от 20 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- Тайвань
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Обзор
The goal of this clinical trial is to learn if there benefits combine enhanced external counterpulsation (EECP) with the standard post-acute care (PAC) rehabilitation treatment to treat stroke patients.. The main questions it aims to answer are: What is the feasibility of combining EECP and PAC? Does EECP combined PAC rehabilitation improve functional outcomes of post-stroke patients? Researchers will compare standard PAC rehabilitation and EECP combined PAC rehabilitation to see if EECP has benefits to treat stroke.
Вмешательства
- Устройство enhanced external counterpulsation
Enhanced External Counterpulsation (EECP) is a non-invasive treatment primarily used for patients with angina or heart failure. It involves the application of pressure cuffs to the legs, which inflate and deflate in sync with the cardiac cycle. This enhances blood flow to the heart during diastole, the phase when the heart is resting between beats. The increased pressure promotes coronary artery perfusion, helping to improve oxygen delivery to the heart muscle, reduce angina symptoms, and enhanc - Процедура post acute care
Post-Acute Care (PAC) for stroke patients focuses on improving functional independence, reducing disability, and preventing secondary complications.
Первичные конечные точки
- Modified Rankin Scale (MRS) [Срок оценки: 0, 3, 6, 9 weeks]
- Barthel Activity Daily Living Index [Срок оценки: 0, 3, 6, 9 weeks]
- Lawton-Brody Instrumental Activity Daily Living scale [Срок оценки: 0, 3, 6, 9 weeks]
- Functional Oral Intake Scale [Срок оценки: 0, 3, 6, 9 weeks]
- Mini Nutrition Assessment [Срок оценки: 0, 3, 6, 9 weeks]
- EuroQol Five Dimensions Questionnaire (EQ-5D) [Срок оценки: 0, 3, 6, 9 weeks]
- Berg Balance Scale (BBS) [Срок оценки: 0, 3, 6, 9 weeks]
- Gait speed [Срок оценки: 0, 3, 6, 9 weeks]
- Mini Mental State Examination [Срок оценки: 0, 3, 6, 9 weeks]
- Short Portable Mental Status Questionnaire (SPMSQ) [Срок оценки: 0, 3, 6, 9 weeks]
Вторичные конечные точки (1)
- ankle-brachial index [Срок оценки: 0 and 9 weeks]
Критерии участия
Критерии включения
- Patients with acute cerebrovascular disease, within 1 month after acute attack.
- Stable medical condition: (1). Neurological condition: The neurological condition has not deteriorated for more than 72 hours. (2). Vital signs including blood pressure, heartbeat, and body temperature are stable or controllable for more than 72 hours. (3). No complications such as infection, blood abnormalities, gastrointestinal bleeding, or stable or controllable after treatment.
- Those whose functional status is moderate to moderately severe functional impairment (MRS 3-4) and who are judged by the medical team to have active rehabilitation potential: (1). Have basic cognition, learning ability and willingness. (2) Have sufficient physical strength: able to maintain a sitting position on a wheelchair or bed edge for at least one hour with support. (3). Be able to actively participate in rehabilitation treatment plans.
- Aged over 20 years old
Критерии исключения
- Patients with atrial fibrillation/arrhythmia.
- Within 2 weeks after cardiac catheterization or arterial puncture at the femoral artery puncture site.
- Decompensated heart failure (NYHA class 3 or 4).
- Left ventricular ejection fraction (EF) < 30%.
- Moderate or severe aortic regurgitation.
- Persistent and uncontrolled hypertension (blood pressure persistently >160/100 mmHg).
- Bleeding tendency.
- Active phlebitis/venous disease of the lower extremities.
- Severe vascular occlusive disease of the lower extremities.
- The presence of documented aortic aneurysm/dissection requiring surgical repair.
- Pregnancy.
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Нет
Дизайн исследования
- Распределение
- Нерандомизированное
- Модель
- Параллельные группы
- Маскирование
- Открытое
- Основная цель
- Лечение
Центры проведения
Тайвань · 1 центр
- China Medical University Hospital Taichung East District Branch — Taichung
Идентификаторы
NCT: NCT06711003 · CMUH113-REC3-136